Results 231 to 240 of about 20,383 (304)

Advancements in Graphdiyne‐Based Multiscale Catalysts for Green Hydrogen Energy Conversion

open access: yesAdvanced Intelligent Discovery, EarlyView.
This review systematically explores the fundamental characteristics of graphdiyne (GDY), cutting‐edge field of GDY‐based multiscale catalysts within sustainable energy conversion systems.Special emphasis is placed on the structure‒property relationships in different reactions.
Qian Xiao, Lu Qi, Siao Chen, Yurui Xue
wiley   +1 more source

Evaluating Three Foundation Potentials for Predicting Selected Properties of the Co–Ni–Ru Alloy System

open access: yesAdvanced Intelligent Discovery, EarlyView.
Distributions of intrinsic stacking fault energies (ISFE) among different slip planes in the face‐centered cubic Co2Ni2Ru alloy, predicted by three foundation potentials (DPA, Orb, and SevenNet) and density functional theory (DFT) calculations. This study evaluates the efficacy of three foundation potentials (FPs)—SevenNet, DPA, and Orb—in predicting ...
Subah Mubassira   +8 more
wiley   +1 more source

Deep Learning–Based Extraction of Promising Material Groups and Common Features from High‐Dimensional Data: A Case of Optical Spectra of Inorganic Crystals

open access: yesAdvanced Intelligent Discovery, EarlyView.
We report a novel interpretation method for deep learning models based on feature extraction and clustering. Applying this method to an atomistic line graph neural network (ALIGNN) model trained on optical absorption spectra of 2,681 inorganic compounds obtained from first‐principles calculations, we successfully identify key factors underlying ...
Akira Takahashi   +3 more
wiley   +1 more source

Real-world outcomes of ranibizumab biosimilars in various retinal diseases: a Korean multi-center experience-ROSE Korea Study. [PDF]

open access: yesSci Rep
Song JR   +11 more
europepmc   +1 more source

Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II study. [PDF]

open access: yesRMD Open
Shen N   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy